News | October 08, 2021
CDSCO approves Syntellix implants
This opens up a huge market for the company’s Magnezis implants in India
This opens up a huge market for the company’s Magnezis implants in India
The company plans to expand its portfolio in regulated markets aggressively
The applications navigate through more than 100 workflows across biotech, pharma, healthcare, food, forensics, industrial and applied sciences industries
The aim is to first produce Covid-19 vaccines and then add more vaccines in the years to come
The transaction is anticipated to close in the first quarter of 2022
A total of 8308 stores are open across India and medicines are priced at affordable rates
FUJIFILM will distribute iSWAB bio sampling technologies in Japan
Lilly will continue to maintain its existing operating model for the remaining portfolio of products
According to IQVIA, US sales of Everolimus (Afinitor) tablets were approximately US $ 675 million in the 12 months ending July 2021
Cipla is a leading global pharma company
Subscribe To Our Newsletter & Stay Updated
